SDIC
PGNX

South Dakota Investment Council’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

South Dakota Investment Council’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-13,600
Closed -$69K – 605
2019
Q4 		$69K Hold
13,600
– – ﹤0.01% 573
2019
Q3 		$69K Hold
13,600
– – ﹤0.01% 607
2019
Q2 		$84K Sell
13,600
-23,600
-63% -$114K ﹤0.01% 585
2019
Q1 		$173K Buy
37,200
+28,000
+304% +$127K ﹤0.01% 565
2018
Q4 		$39K Hold
9,200
– – ﹤0.01% 607
2018
Q3 		$58K Buy
+9,200
New +$70.7K ﹤0.01% 608

Other funds holding PGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

South Dakota Investment Council's PGNX Position: Q1 2020 in Review

South Dakota Investment Council sold out of Progenics Pharmaceuticals Inc (PGNX) in Q1 2020, closing a stake of 13,600 shares — an estimated $69K sold.

South Dakota Investment Council first reported a position in PGNX in Q3 2018 and held it in 6 quarters. The position peaked at $173K in Q1 2019. 129 funds tracked by Wall St. Rank hold PGNX as of Q1 2020.

  • South Dakota Investment Council reported no remaining Progenics Pharmaceuticals Inc position as of Q1 2020 after selling out during the quarter.
  • South Dakota Investment Council sold 13,600 Progenics Pharmaceuticals Inc shares in Q1 2020, an estimated $69K.
  • South Dakota Investment Council first reported a position in Progenics Pharmaceuticals Inc in Q3 2018 and held it in 6 quarters.
  • South Dakota Investment Council's Progenics Pharmaceuticals Inc position peaked at $173K in Q1 2019.
  • 129 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q1 2020.

Based on South Dakota Investment Council's 13F filing for Q1 2020, filed 11 May 2020.